Diamyd Medical AB

ISIN SE0022760336Filings at the FI

At a glance

Most recent filing on May 2, 2025 — a grant by Anders Essen-Möller on Apr 30, 2025.

We hold 3 visible filings, going back to September 30, 2024.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

All 3 shown

  • Anders Essen-Möller Chair of the board
    2,616,992 SEKGrant
    TradedApr 30, 2025FiledMay 2, 2025
  • Anna Styrud Chief financial officer
    55,000 SEKOption exercise
    TradedSep 30, 2024FiledOct 1, 2024
  • Ulf Hannelius Chief executive officer
    500,005 SEKOption exercise
    TradedSep 30, 2024FiledOct 1, 2024